SESEN BIO INC (SESN) Stock Fundamental Analysis

NASDAQ:SESN • US8177631053

0.6288 USD
+0.04 (+7.29%)
At close: Mar 7, 2023
0.5832 USD
-0.05 (-7.25%)
After Hours: 3/7/2023, 7:50:19 PM
Overview Stock Chart Technical Analysis Fundamental Analysis Analyst Ratings Earnings Estimates Financials Ownership News
Fundamental Rating

3

Overall SESN gets a fundamental rating of 3 out of 10. We evaluated SESN against 520 industry peers in the Biotechnology industry. No worries on liquidiy or solvency for SESN as it has an excellent financial health rating, but there are worries on the profitability. SESN does not seem to be growing, but still is valued expensively.


Dividend Valuation Growth Profitability Health

2

1. Profitability

1.1 Basic Checks

  • SESN had negative earnings in the past year.
  • In the past year SESN had a positive cash flow from operations.
SESN Yearly Net Income VS EBIT VS OCF VS FCFSESN Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 0 20M -20M -40M -60M -80M -100M

1.2 Ratios

  • The profitability ratios for SESN are negative, so there is not much use analyzing them.
  • SESN's Return On Invested Capital of 14.26% is amongst the best of the industry. SESN outperforms 97.33% of its industry peers.
Industry RankSector Rank
ROA N/A
ROE N/A
ROIC 14.26%
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
SESN Yearly ROA, ROE, ROICSESN Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 0 100 -100 200 300 400

1.3 Margins

  • SESN's Operating Margin of 49.65% is amongst the best of the industry. SESN outperforms 98.90% of its industry peers.
  • SESN's Operating Margin has improved in the last couple of years.
  • SESN does not have Profit Margin and Gross Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM 49.65%
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5Y62.37%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
SESN Yearly Profit, Operating, Gross MarginsSESN Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 0 -2K -4K -6K

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

7

2. Health

2.1 Basic Checks

  • The Return on Invested Capital (ROIC) is just above the Cost of Capital (WACC), so SESN is still creating some value.
  • SESN has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
SESN Yearly Shares OutstandingSESN Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 50M 100M 150M
SESN Yearly Total Debt VS Total AssetsSESN Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 50M 100M 150M 200M

2.2 Solvency

  • SESN has an Altman-Z score of 1.65. This is a bad value and indicates that SESN is not financially healthy and even has some risk of bankruptcy.
  • With a decent Altman-Z score value of 1.65, SESN is doing good in the industry, outperforming 66.67% of the companies in the same industry.
  • There is no outstanding debt for SESN. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Altman-Z 1.65
ROIC/WACC1.61
WACC8.88%
SESN Yearly LT Debt VS Equity VS FCFSESN Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 0 50M -50M 100M 150M

2.3 Liquidity

  • A Current Ratio of 5.54 indicates that SESN has no problem at all paying its short term obligations.
  • The Current ratio of SESN (5.54) is comparable to the rest of the industry.
  • A Quick Ratio of 5.54 indicates that SESN has no problem at all paying its short term obligations.
  • SESN has a Quick ratio (5.54) which is in line with its industry peers.
Industry RankSector Rank
Current Ratio 5.54
Quick Ratio 5.54
SESN Yearly Current Assets VS Current LiabilitesSESN Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 50M 100M 150M 200M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

2

3. Growth

3.1 Past

  • The earnings per share for SESN have decreased strongly by -364.00% in the last year.
  • The Revenue has grown by 816.87% in the past year. This is a very strong growth!
  • The Revenue has been decreasing by -2.41% on average over the past years.
EPS 1Y (TTM)-364%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%455.56%
Revenue 1Y (TTM)816.87%
Revenue growth 3YN/A
Revenue growth 5Y-2.41%
Sales Q2Q%N/A

3.2 Future

  • SESN is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 12.42% yearly.
  • Based on estimates for the next years, SESN will show a very negative growth in Revenue. The Revenue will decrease by -14.87% on average per year.
EPS Next Y-308%
EPS Next 2Y4.02%
EPS Next 3Y19.21%
EPS Next 5Y12.42%
Revenue Next Year-100%
Revenue Next 2Y-41.42%
Revenue Next 3Y-25.99%
Revenue Next 5Y-14.87%

3.3 Evolution

  • When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
SESN Yearly Revenue VS EstimatesSESN Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2020 2021 5M 10M 15M 20M 25M
SESN Yearly EPS VS EstimatesSESN Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 -0.5 -1 -1.5

More info and screens

Find the best growth stocksShow best growing peers

2

4. Valuation

4.1 Price/Earnings Ratio

  • The Price/Earnings Ratio is negative for SESN. In the last year negative earnings were reported.
  • Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for SESN. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A
SESN Price Earnings VS Forward Price EarningsSESN Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 40 60

4.2 Price Multiples

  • Based on the Price/Free Cash Flow ratio, SESN is valued cheaply inside the industry as 97.96% of the companies are valued more expensively.
Industry RankSector Rank
P/FCF 13.31
EV/EBITDA -5.23
SESN Per share dataSESN EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.5 -0.5 -1

4.3 Compensation for Growth

  • SESN's earnings are expected to grow with 19.21% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y4.02%
EPS Next 3Y19.21%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. Dividend

5.1 Amount

  • No dividends for SESN!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

Find the best dividend stocksShow peers with best dividend

SESEN BIO INC

NASDAQ:SESN (3/7/2023, 7:50:19 PM)

After market: 0.5832 -0.05 (-7.25%)

0.6288

+0.04 (+7.29%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryBiotechnology
Earnings (Last)02-28
Earnings (Next)05-08
Inst OwnersN/A
Inst Owner ChangeN/A
Ins Owners1.16%
Ins Owner Change0%
Market Cap127.96M
Revenue(TTM)60.00M
Net Income(TTM)-4.17M
Analysts43.33
Price Target12.24 (1846.56%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)100.94%
Min EPS beat(2)-20.66%
Max EPS beat(2)222.55%
EPS beat(4)3
Avg EPS beat(4)113.84%
Min EPS beat(4)-20.66%
Max EPS beat(4)222.55%
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)1900%
PT rev (3m)1900%
EPS NQ rev (1m)-1900%
EPS NQ rev (3m)-1900%
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 2.13
P/FCF 13.31
P/OCF 13.31
P/B 0.78
P/tB 0.78
EV/EBITDA -5.23
EPS(TTM)-1.16
EYN/A
EPS(NY)-0.09
Fwd EYN/A
FCF(TTM)0.05
FCFY7.51%
OCF(TTM)0.05
OCFY7.51%
SpS0.29
BVpS0.81
TBVpS0.81
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA N/A
ROE N/A
ROCE N/A
ROIC 14.26%
ROICexc N/A
ROICexgc N/A
OM 49.65%
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5Y62.22%
OM growth 3YN/A
OM growth 5Y62.37%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score4
Asset Turnover0.3
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Debt/EBITDA 0
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 5.54
Quick Ratio 5.54
Altman-Z 1.65
F-Score4
WACC8.88%
ROIC/WACC1.61
Cap/Depr(3y)25.56%
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-364%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%455.56%
EPS Next Y-308%
EPS Next 2Y4.02%
EPS Next 3Y19.21%
EPS Next 5Y12.42%
Revenue 1Y (TTM)816.87%
Revenue growth 3YN/A
Revenue growth 5Y-2.41%
Sales Q2Q%N/A
Revenue Next Year-100%
Revenue Next 2Y-41.42%
Revenue Next 3Y-25.99%
Revenue Next 5Y-14.87%
EBIT growth 1Y485.82%
EBIT growth 3YN/A
EBIT growth 5Y58.47%
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y126.61%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y126.61%
OCF growth 3YN/A
OCF growth 5YN/A

SESEN BIO INC / SESN FAQ

Can you provide the ChartMill fundamental rating for SESEN BIO INC?

ChartMill assigns a fundamental rating of 3 / 10 to SESN.


What is the valuation status for SESN stock?

ChartMill assigns a valuation rating of 2 / 10 to SESEN BIO INC (SESN). This can be considered as Overvalued.


How profitable is SESEN BIO INC (SESN) stock?

SESEN BIO INC (SESN) has a profitability rating of 1 / 10.


Can you provide the expected EPS growth for SESN stock?

The Earnings per Share (EPS) of SESEN BIO INC (SESN) is expected to decline by -308% in the next year.